1. Market Research
  2. > Biotechnology Market Trends
  3. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
10 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »


You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-10 of about 13000 reports

Global Biopharmaceutical Statistics

  • September 2016
    25 pages
  • Biopharmaceutic...  

  • Australia  



View report >

Biopharmaceutical Supply in the US

  • October 2016
    12 pages
  • Biopharmaceutic...  

    Monoclonal Anti...  

  • United States  

View report >

Biopharmaceutical Supply in Europe

  • January 2016
    10 pages
  • Biopharmaceutic...  


  • Europe  

View report >

The future of the Biopharmaceutical Industry in Asia and China

  • May 2015
    5 pages
  • Biopharmaceutic...  

  • Asia  


    United States  

View report >

Biopharmaceutical Industry in Japan

  • March 2016
    10 pages
  • Biopharmaceutic...  

  • Japan  

View report >

Biopharmaceutical Industry in France

  • January 2016
    9 pages
  • Biopharmaceutic...  



  • France  

View report >

Biopharmaceutical Industry in Germany

  • December 2016
    13 pages
  • Biopharmaceutic...  

  • Germany  


View report >

Biopharmaceutical Industry in the UK

  • October 2016
    6 pages
  • Biopharmaceutic...  

  • United Kingdom  


    New Zealand  

View report >

Biopharmaceutical Markets in Canada

  • November 2016
    6 pages
  • Biopharmaceutic...  

  • Canada  

View report >

Biopharmaceutical Supply in Brazil

  • March 2016
    11 pages
  • Laboratory Equi...  

  • Brazil  

View report >

Search in Biopharmaceutical Industry (About 13000 reports)
Parent industry: Biotechnology
Related industries: Biological Therapy, Biomaterial, Genetically Modified Organism, Genomics

About 3900 reports

Purchase Reports From Reputable Market Research Publishers
(From £ 58 - £ 5405)

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • £ 5405
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Frontier Pharma: Hepatitis C - Diverse Range Of First-i ...

December 2016 £ 5405

Cancer Vaccines: Technologies And Global Markets

November 2016 £ 5047

Global Laboratory Products Purchasing Trends, 2016–20 ...

December 2016 £ 4636

France Diabetes Care Devices Market Outlook To 2022 - G ...

January 2017 £ 4633

Porcine Vaccine Market, And Porcine Circovirus Associat ...

November 2016 £ 4478

Clostridium Vaccine Market - Global Industry Analysis, ...

November 2016 £ 4478

Human Vaccines Market - Global Industry Analysis, Size, ...

October 2016 £ 4478

Active Pharmaceutical Ingredients/api Market By Type (i ...

January 2017 £ 4338

Immunotherapy Drugs Market By Type Of Drugs, Therapy Ar ...

January 2017 £ 4338

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.